We advised Dynamics Special Purpose Corp., a SPAC, on its IPO and Nasdaq listing

Davis Polk advised Dynamics Special Purpose Corp. on its $230 million initial public offering of 23,000,000 shares of Class A common stock. The shares are listed on the Nasdaq Capital Market. 

The company is a newly incorporated special purpose acquisition company (SPAC) formed for the purpose of effecting an initial business combination. The company intends to focus its search for businesses across the emerging healthcare value chain, including development platforms that enable applications in prevention, diagnosis, treatment or advanced biomaterials, and, within that context, specific categories include life sciences tools, enabling-software, synthetic biology and novel drug discovery.

The Davis Polk corporate team included partners Alan F. Denenberg, Derek Dostal and Oliver Smith and associates W. Soren Kreider IV and Cameron Adamson. Partner Adam Kaminsky and associate Charlotte R. Fabiani provided executive compensation advice. The tax team included partners Mario J. Verdolini and Patrick E. Sigmon and associate Daniel L. Jose. Members of the Davis Polk team are based in the Northern California, New York and Washington DC offices.